Omega Diagnostics Share Price (ODX)

Share Name	Share Symbol	Market	Type	Share ISIN	Share Description
Omega Dia	LSE:ODX	London	Ordinary Share	GB00B1VCP282	ORD 4P

	Price Change	% Change	Share Price	Shares Traded	Last Trade
	+0.00p	+0.00%	15.75p	22,510	05:30:43

Bid Price		Offer Price	High Price	Low Price	Open Price
15.00p		16.50p	15.75p	15.75p	15.75p

Industry Sector	Turnover (m)	Profit (m)	EPS - Basic	PE Ratio	Market Cap (m)
Health Care Equipment & Services	13.55	-6.91	-0.40		20.0

Related Shares
Smith & Nephew (SN.), NMC Health (NMC), Physiomics (PYC), Widecells (WDC)

Omega Diagnostics (ODX) Latest News (1)

Omega Diagnostics News

Date	Time	Source	Headline
19/10/2018	16:27	UKREG	Omega Diagnostics Group PLC Holding(s) in Company
10/10/2018	11:44	ALNC	Omega Diagnostics Posts Interim Drop On Discontinuing Two Businesses
10/10/2018	07:11	ALNCF	Alliance News Flash Headline
10/10/2018	07:00	UKREG	Omega Diagnostics Group PLC Trading Update and Notice of Interim Results
08/10/2018	14:38	UKREG	Omega Diagnostics Group PLC Holding(s) in Company
27/9/2018	14:21	ALNC	Omega Diagnostics CE-Marks Further Five Allergens, Receives New Order
27/9/2018	07:00	UKREG	Omega Diagnostics Group PLC Allergy CE-Mark and first Purchase Order
14/9/2018	11:25	UKREG	Omega Diagnostics Group PLC Result of AGM
10/9/2018	08:56	UKREG	Omega Diagnostics Group PLC Holding(s) in Company
06/8/2018	10:38	ALNC	Omega Diagnostics Shares Drop 13% After It Swings To Annual Loss

More Omega Diagnostics News

Omega Diagnostics Takeover Rumours

Omega Diagnostics (ODX) Share Charts

1 Year Omega Diagnostics Chart

1 Month Omega Diagnostics Chart

Intraday Omega Diagnostics Chart

Omega Diagnostics (ODX) Discussions and Chat

Omega Diagnostics Forums and Chat

Date	Time	Title	Posts
19/10/2018	18:29	Omega Diagnostics - nicely poised for significant growth	931
01/8/2017	08:17	Omega Diagnostics	1,774

Add a New Thread

Omega Diagnostics (ODX) Most Recent Trades

Trade Time	Trade Price	Trade Size	Trade Value	Trade Type
2018-10-19 12:44:23	15.40	3,333	513.28	O
2018-10-19 08:21:22	15.40	12,600	1,940.40	O
2018-10-19 07:01:27	15.38	6,577	1,011.54	O

View all Omega Diagnostics trades in real-time

Omega Diagnostics (ODX) Top Chat Posts

Date	Subject
19/10/2018 09:20	Omega Diagnostics Daily Update: Omega Dia is listed in the Health Care Equipment & Services sector of the London Stock Exchange with ticker ODX. The last closing price for Omega Diagnostics was 15.75p. Omega Dia has a 4 week average price of 14.65p and a 12 week average price of 12.75p. The 1 year high share price is 23.75p while the 1 year low share price is currently 8p. There are currently 126,959,060 shares in issue and the average daily traded volume is 239,961 shares. The market capitalisation of Omega Dia is £19,996,051.95. Read Full Thread Reply
27/9/2018 11:10	rivaldo: Great to see the share price move up nicely on relatively small buying. Perhaps not much stock around/Sneller is mopping it all up. Today's news will help to encourage the market that at last ODX can deliver on its promises, especially with the first IDS purchase order. Read Full Thread Follow Reply
18/7/2018 20:45	barrywhit: Mainly sells today, last year that RNS would have sent the share price 2p higher, now we have no P.I's so a few traders taking a profit..... Read Full Thread Follow Reply
25/5/2018 10:43	hyperboreus: Having eventually managed to find the presentation slides on the website I have to say that I am not surprised at all that the share price has dropped since. Really amateurish effort in my opinion with confusing graphics and lacking clarity in general. The only vaguely positive note I could find is at the bottom of page 14: 'Confident revised strategy will deliver increased shareholder value' Hopeless effort really, probably a waste of time and yet more money! Read Full Thread Follow Reply
23/5/2018 15:23	jeevsje: Judging by the share price movement, it appears the event was a failure and investors have lost faith in the directors. They did not even have the balls to make meaningful buys, just some petty buys. Read Full Thread Follow Reply
21/5/2018 08:23	barrywhit: The trouble is they have lost most of their P.I's hence the lack of trades this morning. It is P.I's that move the share price not Institutions or Directors they only buy when the share price is struggling or Placings....They will need to start to show increased sales figures to attract new investors imho... Read Full Thread Follow Reply
24/4/2018 22:11	p1nkfish: I will keep a runt of shares for general interest. When you feel deceived by management it doesn't matter what subsequently happens to the share price. Trust is gone. For how long have we been led to believe ODX management was competent? Even down to selling German property to lease back to fund "growth". I thought they were being careful with news to cool down any speculation. Fact is they didn't have much to shout about and were keeping stum so suckers like me couldn't work out they were winging it. Sneller is trapped, where is he going to off-load his stock except in a wind down? He made mistakes on PIM, hope it doesn't repeat here. Mills is an excellent value man and speculator. I doubt this is a conviction buy for him else he would be closer to 20% imho. Management will be instructed what to do and hopefully will execute accordingly and not acquire delusions of competence along the way. I hope you all make a packet from this. Read Full Thread Follow Reply
20/4/2018 21:51	hyperboreus: Well usually I agree with you p1nkfish but not on this occasion however as I would never ever trust any organistation that issues a trading update at close of play on a Friday afternoon, absolute shysters from my standpoint. It would appear to me that Immunodiagnostic Systems or IDS as they like to call themselves are about as clueless and trustworthy as our lot, no wonder it took nearly 18 months to sort the so called distribution agreement out. Anyhow that non event is really irrelevant to me now as it would appear the most pertinent happening today is the volume of 10,320,600 shares traded equating to around 8% of total shares in issue, which I do not believe I have seen whilst I have been an ODX shareholder during the past 6 years. The ODX RNS clearly has very little to do with the rise in share price but the 4.5 million x 2 trades @ 08:39hrs followed by the 0.5 million @ 08:58hrs this morning are intriguing. It is all conjecture until a formal announcement is made but I would think and longingly hope that an external third party has taken an interest in proceedings here. Hopefully the 'Balls Up Investor Presentation Jobby' on 21 May 2018 when no new information will be disclosed will not be necessary as Messrs King, Harbinson & Grewal will looking for alternative employment! Have a great weekend 😝 Read Full Thread Follow Reply
06/4/2018 11:53	hyperboreus: Another 8 months away yet but Messrs Evans, Shepherd and Harbinson each have options granted on 10 December 2008 with an exercise price of 19p which expire on 10 December 2018. No idea what is likely to propel the share price north of 19p in the short term, just shows how their expectations of how Omega would perform over the last 10 years have just not materialised. In a perverse way I almost hope that the share price doesn't rise too much this year as they do not deserve to profit from them in my opinion, that is my 'gripe of the day' out of the way now! 😧 Read Full Thread Follow Reply
25/1/2018 12:03	hyperboreus: I am not going anywhere here having initially bought in in March 2012 but as I have stated before there is unlikely to be much positive newsflow short term therefore sliding share price is perfectly understandable but beyond that there should be plenty to look forward to. I personally don't think it is a good idea to obsess about the share price too much at the moment, some investors are clearly losing patience which any reasonable individual should be able to comprehend given the questionable financial performance of the Company in the last few years, but hopefully everything will come together in the next 12-18 months, if not I think something will have to give and the Company may well be bought out, the patience of Sneller and other major investors cannot be inexhaustible. Read Full Thread Follow Reply
23/1/2017 16:12	hyperboreus: Looking like you might get your wish longshanks re 16.5p Been having a really in depth look at all the director share options and the first tranche issued to Evans, Shepherd and Harbinson with exercise price at 19p expire on 10 December 2018 having been issued on 10 December 2008. I am sure they would have been expecting ODX's share price to be much higher by now over 9 years later as it has gone nowhere really since then. The next sizeable batch issued to Shepherd, Harbinson and Grewal with exercise price at 14.5p expire on 5 July 2022 but share price must be 25p or higher. Interestingly David Evans doesn't have any other options other than the one which expires next December, but having said that he was very generously 'allowed' to purchase 2,760,134 shares at 12p on 17 Dec 2010 in a private placing in relation to the purchase of the ALLERGOPHARMA IVD BUSINESS. His average share price purchase by the way is 12.81p, Jag Grewal's is 19.92p, not so easy to work out Harbinson's and Shepherd's as they they were directors in ODX before reverse takeover in 2006 but my best guess for Harbinson is 12.88p and 9.38p for Shepherd. My average share price in ODX has gone up significantly from my first purchase in April 2012 at 10.25p but at just over 16p I am still confident that exciting times are ahead, just not sure how long I might have to wait like the rest of us! Read Full Thread Follow Reply

Omega Diagnostics share price data is direct from the London Stock Exchange

add chat code

Your Recent History

LSE

GKP

Gulf Keyst..

LSE

QPP

Quindell

FTSE

UKX

FTSE 100

LSE

IOF

Iofina

GBPUSD

UK Sterlin..

Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil

ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico

ADVFN France ADVFN US Finance Manila

P:33 V: D:20181020 00:00:33